Medtronic Q3 Adjusted EPS $1.30 Beats $1.26 Estimate, Sales $8.09B Beat $7.95B Estimate
Portfolio Pulse from Benzinga Newsdesk
Medtronic reported Q3 earnings of $1.30 per share, surpassing the $1.26 estimate, and sales of $8.09B, exceeding the $7.95B estimate. This represents a 4.68% increase in sales compared to the same period last year.
February 20, 2024 | 11:47 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic's Q3 earnings and sales exceeded analyst expectations, with a notable year-over-year sales increase.
Medtronic's better-than-expected Q3 earnings and sales figures, along with a significant year-over-year sales growth, are likely to positively influence investor sentiment and potentially lead to a short-term uptick in its stock price. The company's performance indicates operational efficiency and market strength, which are key factors investors look for.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100